Compara mètodes
Revisa els mètodes seleccionats l'un al costat de l'altre; les files que difereixen es ressalten.
| Escalat Farmacocinètic Al·lomètric× | Modelització Farmacodinàmica Poblacional× | |
|---|---|---|
| Camp | Farmacologia | Farmacologia |
| Família | Process / pipeline | Process / pipeline |
| Any d'origen≠ | 1989 | 1992 |
| Autor original≠ | John Mordenti | Lewis Sheiner and Stephen Roush |
| Tipus≠ | inter-species extrapolation | dose-response modeling |
| Font seminal≠ | Mordenti, J., & Chappell, W. (1989). The use of allometric scaling in toxicokinetic studies. Fundamental and Applied Toxicology, 13(2), 335-346. link ↗ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ |
| Àlies | allometric scaling, inter-species extrapolation, FIH dose prediction | PopPD, population PD, hierarchical PD modeling |
| Relacionats | 3 | 3 |
| Resum≠ | Allometric scaling is a mathematical approach for predicting human pharmacokinetics from preclinical animal data using body weight relationships. Developed systematically by Mordenti and colleagues in the late 1980s, it enables rational first-in-human dose prediction without assuming species-specific metabolic differences. | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. |
| ScholarGateConjunt de dades ↗ |
|
|